We are advised by ACT Genomics that journalists and other readers should disregard the news release, ACT Genomics, AstraZeneca enter Collaboration for BRCA Testing in Singapore and Taiwan, issued 01-Feb-2018 over PR Newswire. We are advised by the company that the release was sent in error.
